German biotech firm BioNTech plans to commence clinical trials of a possible malaria vaccine by the end of 2022 as the annual death toll attributed to the disease surpasses 400,000 people, many of them in Africa.
Malawi has launched a campaign to eradicate malaria, which accounts for 15% of all the country’s hospital admissions, by 2030.